Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

The treatment combination is effective and generally safe for lung cancer.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Oral tofacitinib may effectively regrow hair in children with alopecia areata unresponsive to other treatments.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

ALRN-6924 may prevent hair loss caused by chemotherapy.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.